Gilmore Neil O'neill - Net Worth and Insider Trading
Gilmore Neil O'neill Net Worth
The estimated net worth of Gilmore Neil O'neill is at least $2 Million dollars as of 2024-05-13. Gilmore Neil O'neill is the CEO of Editas Medicine Inc and owns about 327,470 shares of Editas Medicine Inc (EDIT) stock worth over $2 Million. Details can be seen in Gilmore Neil O'neill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gilmore Neil O'neill has not made any transactions after 2024-03-05 and currently still holds the listed stock(s).
Transaction Summary of Gilmore Neil O'neill
Gilmore Neil O'neill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gilmore Neil O'neill owns 4 companies in total, including Sarepta Therapeutics Inc (SRPT) , Unity Biotechnology Inc (UBX) , and Aptinyx Inc (APTX) among others .
Click here to see the complete history of Gilmore Neil O'neill’s form 4 insider trades.
Insider Ownership Summary of Gilmore Neil O'neill
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2018-06-07 | SVP & Chief Medical Officer |
| UBX | Unity Biotechnology Inc | 2020-12-10 | director |
| APTX | Aptinyx Inc | 2021-10-19 | director |
 | | 2024-03-05 | director & CEO |
Gilmore Neil O'neill Latest Holdings Summary
Gilmore Neil O'neill currently owns a total of 1 stock. Gilmore Neil O'neill owns 327,470 shares of Editas Medicine Inc (EDIT) as of March 5, 2024, with a value of $2 Million.
Latest Holdings of Gilmore Neil O'neill
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EDIT | Editas Medicine Inc | 2024-03-05 | 327,470 | 5.32 | 1,742,140 |
Holding Weightings of Gilmore Neil O'neill
Gilmore Neil O'neill Form 4 Trading Tracker
According to the SEC Form 4 filings, Gilmore Neil O'neill has made a total of 2 transactions in Editas Medicine Inc (EDIT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Editas Medicine Inc is the sale of 77,824 shares on March 5, 2024, which brought Gilmore Neil O'neill around $733,102.
Insider Trading History of Gilmore Neil O'neill
- 1
Gilmore Neil O'neill Trading Performance
Gilmore Neil O'neill Ownership Network
Gilmore Neil O'neill Owned Company Details
What does Sarepta Therapeutics Inc do?
Who are the key executives at Sarepta Therapeutics Inc?
Gilmore Neil O'neill is the SVP & Chief Medical Officer of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Tech Ops Officer Bilal Arif , Chief Financial Officer Ian Michael Estepan , and SVP & General Counsel Ryan Edward Brown .
Sarepta Therapeutics Inc (SRPT) Insider Trades Summary
Over the past 18 months, Gilmore Neil O'neill made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 68,532 shares made by Michael Andrew Chambers , a net sale of 30,000 shares made by Wigzell Hans Lennart Rudolf , and a net sale of 3,993 shares made by Stephen Mayo .
In summary, during the past 3 months, insiders sold 27,731 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 0 shares, with a net sale of 27,731 shares. During the past 18 months, 43,589 shares of Sarepta Therapeutics Inc (SRPT) were sold and 143,757 shares were bought by its insiders, resulting in a net purchase of 100,168 shares.
Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sarepta Therapeutics Inc Insider Transactions
Gilmore Neil O'neill Mailing Address
Above is the net worth, insider trading, and ownership report for Gilmore Neil O'neill. You might contact Gilmore Neil O'neill via mailing address: 215 First Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
